Anal cancer screening with post-hra treatment

Anal cancer screening with post-hra treatment has been studied in 1 paper since 2026: none in people yet; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Nov 19, 2026: “Comparative cost-effectiveness of HPV mRNA and DNA testing for anal cancer screening in MSM living with HIV: a model-based…”.

Exposure

1 paper studies it1 findingUpdated

1 new paper in 30 daysSee all 1 papers on anal cancer screening with post-hra treatment

  • In silico1

What did studies of anal cancer screening with post-hra treatment find?

1

Studies of anal cancer screening with post-hra treatment measured one outcome, anal cancer incidence.

Anal cancer incidence

downin silico1

1 study
  1. Anal cancer screening with post-hra treatment decreases anal cancer incidence in silico (Simulated MSM living with HIV; compared with no screening) (43–69% reduction compared with no screening).

    In silicoSimulated MSM living with HIV; compared with no screeningmales

More on Anal cancer incidence

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months